Globally, the stem cell therapy market is expected to be worth $40 billion by 2020 and $180 billion by 2030. The most significant number of marketed cell therapy products is used for the treatment of notably non-healing wounds/skin (46%) and muscular-skeletal injuries (35%). This trend will change as more and stem cell therapy products for cancer and heart disease complete their clinical trials and are approved for market release.
Adult stem cell leads the market due to low contamination during sub-culture and expansion, relatively small labor production and compatibility with the human body. Just the Induced pluripotent stem cells (IPSc’s) are expected to report revenue of over USD 4.5 billion by 2020, on account of the similar nature of its origin. With the continued growth of medical tourism hubs like India, Singapore, and Thailand, Asia is expected to maintain its place as the epicenter of stem cell research and therapy. These opportunities include contract research outsourcing and rising patient population with neurological and other chronic conditions in the region. Japan, Singapore, and South Korea are the frontrunners and are set to dominate the APAC stem cell market in the coming years.
Cell Therapy World Asia 2020 is bringing together Asia’s best of best in cell therapy development and manufacturing. This will be the most targeted and the only regional conference that will attract cell therapy companies in South Korea, Japan, China, India, Singapore, Taiwan and the rest of Asia to discuss and debate on best practices and innovations in this space.
Antonio Lee Medipost America Inc
Sangmin Lee Samsung Bioepis
Suyamburam Sathasivam Sunpharma
Jongman Yoo Organoid Science
Gail Naughton Histogen
Namshik Kim Pharma CRO
Kshitij Soni Credevo
Cell Therapy World Asia will provide commercial organizations with the opportunity to educate the market about what to offer. It will help you in terms of leadership roles in the field alongside crucial industry figures. Host innovative round – table sessions of up to 20 industry professionals around critical topics and exclusive workshops/master-class of up to 50 end- users. Therefore, raising brand awareness will be an advantage and enjoy the option of privately arranged meetings and consultations with selected potential clients. Also, you will get the chance to hold face to face meetings with your target profile.
Attendee list for Cell Therapy World Asia
NEW! Exclusive Presentation Insights
Upcoming Partnerships in Japanese Cell Therapy
Top 50 Asian Cell Therapy Companies
Top Cell Therapy Pipelines in Asia Pacific
Leaders in Asian Cell Therapy Industry
For any queries regarding venue or accommodation, please contact:
Si Hui Sim
Senior Operations Executive
T: +65 3109 0224